Cite
HARVARD Citation
Lon, H. et al. (2019). Pharmacokinetics, Safety, Tolerability, and Pharmacodynamics of Alicapistat, a Selective Inhibitor of Human Calpains 1 and 2 for the Treatment of Alzheimer Disease: An Overview of Phase 1 Studies. Clinical pharmacology in drug development. 8 (3), pp. 290-303. [Online].